Smithfield Trust’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$392K Sell
5,541
-777
-12% -$61.3K 0.02% 279
2025
Q4
$519K Hold
6,318
0.02% 231
2025
Q3
$476K Hold
6,318
0.02% 236
2025
Q2
$468K Hold
6,318
0.02% 228
2025
Q1
$507K Hold
6,318
0.03% 220
2024
Q4
$493K Sell
6,318
-912
-13% -$77.5K 0.02% 219
2024
Q3
$679K Buy
7,230
+2,290
+46% +$192K 0.03% 198
2024
Q2
$385K Buy
4,940
+12
+0.2% +$979 0.02% 226
2024
Q1
$448K Sell
4,928
-208
-4% -$17.3K 0.02% 218
2023
Q4
$398K Hold
5,136
0.02% 224
2023
Q3
$349K Sell
5,136
-65
-1% -$4.73K 0.02% 225
2023
Q2
$422K Sell
5,201
-171
-3% -$13.6K 0.03% 218
2023
Q1
$441K Buy
+5,372
New +$384K 0.03% 203

Other funds holding GEHC

Smithfield Trust's GEHC Position: Q1 2026 in Review

Smithfield Trust reduced its GE HealthCare (GEHC) stake by 12% in Q1 2026, selling an estimated $61.3K and leaving 5,541 shares worth $392K. The position accounts for 0.02% of the portfolio, ranked #279.

Smithfield Trust first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $679K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Smithfield Trust held 5,541 shares of GE HealthCare worth $392K as of Q1 2026.
  • Smithfield Trust sold 777 GE HealthCare shares in Q1 2026, an estimated $61.3K.
  • GE HealthCare made up 0.02% of Smithfield Trust's portfolio in Q1 2026, its #279 holding.
  • Smithfield Trust first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Smithfield Trust's GE HealthCare position peaked at $679K in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.